Index by author

01 January 2005; volume 25, issue 1

A

  1. Abadie, Y.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  2. Adnot, S.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  3. Alegre, J.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  4. Alemán, C.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  5. Amano, S.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  6. Anderson, G. P.

    1. Lindén, A., M. Laan, and G. P. Anderson. "Neutrophils, interleukin-17A and lung disease." European Respiratory Journal 25.1 (2005): 159-172. Web. 19 April. 2021.

  7. Anglés, A.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  8. Aris, R. M.

    1. Aris, R. M., and T. A. Guise. "Cystic fibrosis and bone disease: are we missing a genetic link?." European Respiratory Journal 25.1 (2005): 9-11. Web. 19 April. 2021.

  9. Armadans, L. I.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  10. Atis, S.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  11. Austin, P.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

B

  1. Bailey, M.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

  2. Bartalesi, B.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

  3. Bensberg, R.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  4. Bödeker, R. H.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  5. Bohnen, A. M.

    1. Ponsioen, B. P. et al "Efficacy of fluticasone on cough: a randomised controlled trial." European Respiratory Journal 25.1 (2005): 147-152. Web. 19 April. 2021.

  6. Boitano, L. J.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

  7. Borst, M. M.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  8. Brackhahn, W.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  9. Brand, P.

    1. Shaker, S. B. et al "Quantitative computed tomography and aerosol morphometry in COPD and α1-antitrypsin deficiency." European Respiratory Journal 25.1 (2005): 23-30. Web. 19 April. 2021.

  10. Bregeon, F.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  11. Brunekreef, B.

    1. de Meer, G. et al "Airway responsiveness to hypertonic saline: dose-response slope or PD15?." European Respiratory Journal 25.1 (2005): 153-158. Web. 19 April. 2021.

  12. Bugnon, D.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

C

  1. Calverley, P. M. A.

    1. Calverley, P. M. A., and N. G. Koulouris. "Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology." European Respiratory Journal 25.1 (2005): 186-199. Web. 19 April. 2021.

  2. Cavarra, E.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

  3. Chailley-Heu, B.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  4. Chan, K. H.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  5. Chan, K. S.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  6. Chan, V. L.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  7. Chee, C. B. E.

    1. Chee, C. B. E., J. L. Da Costa, and C. S. Sim. "A female with dry cough, progressive dyspnoea and weight loss." European Respiratory Journal 25.1 (2005): 206-209. Web. 19 April. 2021.

  8. Cheng, V. C. C.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  9. Chu, C. M.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  10. Civello, D.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

  11. Collins, R.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  12. Colombeix, C.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

D

  1. Da Costa, J. L.

    1. Chee, C. B. E., J. L. Da Costa, and C. S. Sim. "A female with dry cough, progressive dyspnoea and weight loss." European Respiratory Journal 25.1 (2005): 206-209. Web. 19 April. 2021.

  2. Debillon, T.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  3. de Jongste, J. C.

    1. de Meer, G. et al "Airway responsiveness to hypertonic saline: dose-response slope or PD15?." European Respiratory Journal 25.1 (2005): 153-158. Web. 19 April. 2021.

  4. Dekhuijzen, P. N. R.

    1. Ponsioen, B. P. et al "Efficacy of fluticasone on cough: a randomised controlled trial." European Respiratory Journal 25.1 (2005): 147-152. Web. 19 April. 2021.

  5. Delclaux, C.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  6. Dembinski, R.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  7. de Meer, G.

    1. de Meer, G. et al "Airway responsiveness to hypertonic saline: dose-response slope or PD15?." European Respiratory Journal 25.1 (2005): 153-158. Web. 19 April. 2021.

  8. Deschaux, C.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  9. De Vuyst, P.

    1. Vermeire, P., and P. De Vuyst. "In memoriam Jean-Claude Yernault, 1943–2004." European Respiratory Journal 25.1 (2005): 1-2. Web. 19 April. 2021.

  10. Dinh-Xuan, A. T.

    1. Naeije, R., and A. T. Dinh-Xuan. " From the authors ." European Respiratory Journal 25.1 (2005): 212. Web. 19 April. 2021.

  11. Dirksen, A.

    1. Shaker, S. B. et al "Quantitative computed tomography and aerosol morphometry in COPD and α1-antitrypsin deficiency." European Respiratory Journal 25.1 (2005): 23-30. Web. 19 April. 2021.

  12. Duong, M.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  13. Duvaldestin, P.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

E

  1. Ebeling, P. R.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

  2. Efthimiadis, A.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  3. Eklund, A.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

F

  1. Fegbeutel, C.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  2. Fernández de Sevilla, T.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  3. Fineschi, S.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

G

  1. Goldstein, R.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  2. Grant, B.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  3. Gras-Le Guen, C.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  4. Grasemann, C.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

  5. Grasemann, H.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

  6. Grebe, M.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  7. Griffith, L. E.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  8. Gripenbäck, S.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  9. Grunewald, J.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  10. Guise, T. A.

    1. Aris, R. M., and T. A. Guise. "Cystic fibrosis and bone disease: are we missing a genetic link?." European Respiratory Journal 25.1 (2005): 9-11. Web. 19 April. 2021.

  11. Guyatt, G. H.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

H

  1. Haeussermann, S.

    1. Shaker, S. B. et al "Quantitative computed tomography and aerosol morphometry in COPD and α1-antitrypsin deficiency." European Respiratory Journal 25.1 (2005): 23-30. Web. 19 April. 2021.

  2. Hallstrand, T. S.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

  3. Hanaoka, Y.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  4. Hargreave, F. E.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  5. Hayes, J. G.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

  6. Henzler, D.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  7. Homma, S.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

  8. Hop, W. C. J.

    1. Ponsioen, B. P. et al "Efficacy of fluticasone on cough: a randomised controlled trial." European Respiratory Journal 25.1 (2005): 147-152. Web. 19 April. 2021.

  9. Hughes, J. M. B.

    1. Hughes, J. M. B.. "The hepatopulmonary syndrome: NO way out?." European Respiratory Journal 25.1 (2005): 211-212. Web. 19 April. 2021.

  10. Hüsken, H.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

I

  1. Iglesias, D.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  2. Ishii, M.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  3. Ishii, T.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

J

  1. Jarry, A.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  2. Jayaram, L.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  3. Johnson, W. C.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

K

  1. Kamada, D.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  2. Kanik, A.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  3. Kasahara, Y.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  4. Katus, H. A.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  5. Kimura, A.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  6. King, S. J.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

  7. Kishi, K.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

  8. Kotsimbos, T.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

  9. Koulouris, N. G.

    1. Calverley, P. M. A., and N. G. Koulouris. "Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology." European Respiratory Journal 25.1 (2005): 186-199. Web. 19 April. 2021.

  10. Kristen, A. V.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  11. Kübler, W.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  12. Kuhlen, R.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  13. Kuriyama, T.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  14. Kurtz, F.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

L

  1. Laan, M.

    1. Lindén, A., M. Laan, and G. P. Anderson. "Neutrophils, interleukin-17A and lung disease." European Respiratory Journal 25.1 (2005): 159-172. Web. 19 April. 2021.

  2. Laboisse, C. L.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  3. Lam, J. Y. M.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  4. Lange, F.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  5. Lauterbach, K. W.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

  6. Leung, W. S.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  7. Levent, E.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  8. Lévy, P.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  9. Lidén, C.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  10. Lin, A. W. N.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

  11. Lindén, A.

    1. Lindén, A., M. Laan, and G. P. Anderson. "Neutrophils, interleukin-17A and lung disease." European Respiratory Journal 25.1 (2005): 159-172. Web. 19 April. 2021.

  12. Lossnitzer, D.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  13. Lucattelli, M.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

  14. Luengen, M.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

  15. Lundgren, L.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  16. Lungarella, G.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

  17. Lunghi, B.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

M

  1. Mador, M. J.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  2. Maitre, B.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  3. Maltbaek, N.

    1. Shaker, S. B. et al "Quantitative computed tomography and aerosol morphometry in COPD and α1-antitrypsin deficiency." European Respiratory Journal 25.1 (2005): 23-30. Web. 19 April. 2021.

  4. Marks, G. B.

    1. de Meer, G. et al "Airway responsiveness to hypertonic saline: dose-response slope or PD15?." European Respiratory Journal 25.1 (2005): 153-158. Web. 19 April. 2021.

  5. Martorana, P. A.

    1. Bartalesi, B. et al "Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants." European Respiratory Journal 25.1 (2005): 15-22. Web. 19 April. 2021.

  6. Mazza, S.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  7. McKim, D.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  8. Meyer, F. J.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  9. Miyamoto, A.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

  10. Monasterio, J.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  11. Morice, A. H.

    1. Morice, A. H.. " From the author ." European Respiratory Journal 25.1 (2005): 211. Web. 19 April. 2021.

  12. Motoi, N.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

N

  1. Naëgelé, B.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  2. Naeije, R.

    1. Naeije, R., and A. T. Dinh-Xuan. " From the authors ." European Respiratory Journal 25.1 (2005): 212. Web. 19 April. 2021.
    2. Naeije, R.. "Breathing more with weaker respiratory muscles in pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 6-8. Web. 19 April. 2021.

  3. Namba, R.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  4. Nemery, B.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  5. Nyulasi, I. B.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

O

  1. Okada, O.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  2. Okada, T.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  3. Oktay, I.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  4. Ouchi, Y.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  5. Ozturk, C.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

P

  1. Papazian, L.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  2. Pépin, J-L.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  3. Pizzichini, E.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  4. Pizzichini, M. M. M.

    1. Jayaram, L. et al "Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma." European Respiratory Journal 25.1 (2005): 41-46. Web. 19 April. 2021.

  5. Plante, J.

    1. Mazza, S. et al "Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests." European Respiratory Journal 25.1 (2005): 75-80. Web. 19 April. 2021.

  6. Ponsioen, B. P.

    1. Ponsioen, B. P. et al "Efficacy of fluticasone on cough: a randomised controlled trial." European Respiratory Journal 25.1 (2005): 147-152. Web. 19 April. 2021.

  7. Potel, G.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  8. Puhan, M.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

R

  1. Rabe, K. F.

    1. Sterk, P. J., and K. F. Rabe. "Serving researchers, the impact factor and other conflicts of interest." European Respiratory Journal 25.1 (2005): 3-5. Web. 19 April. 2021.

  2. Raghu, G.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

  3. Ratjen, F.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

  4. Redaelli, M.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

  5. Rieder, H.

    1. Rieder, H.. "Annual risk of infection with Mycobacterium tuberculosis." European Respiratory Journal 25.1 (2005): 181-185. Web. 19 April. 2021.

  6. Rossaint, R.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  7. Rott, A.

    1. Dembinski, R. et al "Cardiopulmonary effects of iloprost in experimental acute lung injury." European Respiratory Journal 25.1 (2005): 81-87. Web. 19 April. 2021.

  8. Roze, J-C.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  9. Ruíz, E.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

S

  1. Sahin, K.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  2. Sakamoto, S.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

  3. Saral, A.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  4. Schoene, A. M.

    1. Meyer, F. J. et al "Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension." European Respiratory Journal 25.1 (2005): 125-130. Web. 19 April. 2021.

  5. Schulz, R.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  6. Schünemann, H. J.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  7. Seeger, W.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  8. Segura, R. M.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  9. Shaker, S. B.

    1. Shaker, S. B. et al "Quantitative computed tomography and aerosol morphometry in COPD and α1-antitrypsin deficiency." European Respiratory Journal 25.1 (2005): 23-30. Web. 19 April. 2021.

  10. Shibata, H.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  11. Sim, C. S.

    1. Chee, C. B. E., J. L. Da Costa, and C. S. Sim. "A female with dry cough, progressive dyspnoea and weight loss." European Respiratory Journal 25.1 (2005): 206-209. Web. 19 April. 2021.

  12. Skare, L.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  13. Soriano, T.

    1. Iglesias, D. et al "Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions." European Respiratory Journal 25.1 (2005): 104-109. Web. 19 April. 2021.

  14. Spada, C. A.

    1. Hallstrand, T. S. et al "The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis." European Respiratory Journal 25.1 (2005): 96-103. Web. 19 April. 2021.

  15. Stahl, E.

    1. Schünemann, H. J. et al "A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire." European Respiratory Journal 25.1 (2005): 31-40. Web. 19 April. 2021.

  16. Sterk, P. J.

    1. Sterk, P. J., and K. F. Rabe. "Serving researchers, the impact factor and other conflicts of interest." European Respiratory Journal 25.1 (2005): 3-5. Web. 19 April. 2021.

  17. Stock, S.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

T

  1. Takahashi, M.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  2. Takizawa, M.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  3. Tanabe, N.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  4. Tatsumi, K.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  5. Teramoto, S.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  6. Thomas, P.

    1. Abadie, Y. et al "Decreased VEGF concentration in lung tissue and vascular injury during ARDS." European Respiratory Journal 25.1 (2005): 139-146. Web. 19 April. 2021.

  7. Tietze-Schillings, G.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

  8. Tillmanns, H.

    1. Schulz, R. et al "Changes in extracranial arteries in obstructive sleep apnoea." European Respiratory Journal 25.1 (2005): 69-74. Web. 19 April. 2021.

  9. Topliss, D. J.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

  10. Toquet, C.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  11. Tornling, G.

    1. Gripenbäck, S. et al "Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust." European Respiratory Journal 25.1 (2005): 118-124. Web. 19 April. 2021.

  12. Tunaci, A.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

  13. Tutluoglu, B.

    1. Atis, S. et al "The respiratory effects of occupational polypropylene flock exposure." European Respiratory Journal 25.1 (2005): 110-117. Web. 19 April. 2021.

V

  1. Vallette, G.

    1. Gras-Le Guen, C. et al "Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung." European Respiratory Journal 25.1 (2005): 88-95. Web. 19 April. 2021.

  2. Vermeire, P.

    1. Vermeire, P., and P. De Vuyst. "In memoriam Jean-Claude Yernault, 1943–2004." European Respiratory Journal 25.1 (2005): 1-2. Web. 19 April. 2021.

  3. Vermue, N. A.

    1. Ponsioen, B. P. et al "Efficacy of fluticasone on cough: a randomised controlled trial." European Respiratory Journal 25.1 (2005): 147-152. Web. 19 April. 2021.

  4. Vester, U.

    1. Grasemann, H. et al "Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study." European Respiratory Journal 25.1 (2005): 62-68. Web. 19 April. 2021.

W

  1. Wendland, G.

    1. Stock, S. et al "Asthma: prevalence and cost of illness." European Respiratory Journal 25.1 (2005): 47-53. Web. 19 April. 2021.

  2. Wilson, J. W.

    1. King, S. J. et al "Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor." European Respiratory Journal 25.1 (2005): 54-61. Web. 19 April. 2021.

Y

  1. Yamaguchi, Y.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  2. Yamamoto, H.

    1. Teramoto, S. et al "Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia." European Respiratory Journal 25.1 (2005): 210-211. Web. 19 April. 2021.

  3. Yasunami, M.

    1. Tanabe, N. et al "Association of clinical features with HLA in chronic pulmonary thromboembolism." European Respiratory Journal 25.1 (2005): 131-138. Web. 19 April. 2021.

  4. Yoshimura, K.

    1. Homma, S. et al "Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide." European Respiratory Journal 25.1 (2005): 200-204. Web. 19 April. 2021.

  5. Yuen, K. Y.

    1. Chu, C. M. et al "Duration of RT-PCR positivity in severe acute respiratory syndrome." European Respiratory Journal 25.1 (2005): 12-14. Web. 19 April. 2021.

Z

  1. Zieliński, J.

    1. Zieliński, J.. "Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans." European Respiratory Journal 25.1 (2005): 173-180. Web. 19 April. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts